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Objectives: Assess the effects of a home exercise programme, based on aerobic training and
muscle strength training, in patients with cystic fibrosis (CF), for a period of 3 months.
Methods: Randomised controlled clinical experiment, with an analysis of intention to treat
including clinically stable patients with CF and of age  16. Assessments include: a 6 min walk
test (6 MWT), one-repetition maximum strength test (1 RM), spirometry and quality of life
questionnaires. The patients randomised for the exercise group exercise group followed a
home exercise protocol, supervised by telephone, while the control group maintained their
usual activities.
Results: 41 Patients were included, 22 in the control group and 19 in the exercise group. The
exercise group presented a significant increase in muscle strength in upper limbs (UULL) on the
1 RM test. There was no significant difference between groups on the scores for general quality
of life and specifically for CF and in the distance walked on the 6 MWT.
Conclusion: The study demonstrated that a home exercise programme had positive effects in
adult patients with CF, including gain in muscle strength in UULL. No increase in tolerance to
exercise was shown and improvement in the quality of life of the patients who received inter-
vention.
ª 2014 Elsevier Ltd. All rights reserved.os Cresceˆncio 185/502CEP: 90650-090, Brazil. Tel.: þ55 51 32171757.
metodistadosul.edu.br, larove_@hotmail.com (P.T.R. Dalcin).
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Cystic fibrosis (CF) is a hereditary disease most common in
the white population [1]. The clinical expression of the
disease is very varied in general, showing multi-systemic
involvement, characterised by intestinal motility, male
infertility and high concentrations of electrolytes in sweat.
However, pulmonary impairment is the main determinant
of morbidity and mortality related to the disease [2,3].
Patients with CF frequently present a progressive limi-
tation to physical exercise and reduction of their daily life
activities [4e7]. However, when submitted to physical ac-
tivity programmes, these patients present an increase in
tolerance to exercise, improvement in cardiorespiratory
function, in respiratory muscle endurance and in immuno-
logical function [8e12].
Training with aerobic exercise has been associated with
improvement in the prognostic of patients with CF [11]. The
best results were reached with supervised training pro-
grammes [5e14].
An important alternative to be considered in this
population of patients would be to institute a home ex-
ercise programme supervised by the health care team.
These home programmes correspond to a proposal closer
to the reality of this population, that is, patients with
varying seriousness of the disease, residents in different
locations, with no possibility of carrying out the exercise
protocol with weekly presential intervention at the
centre, could benefit from this intervention. However,
evidence of benefit from this approach is still precarious
[16e18].
The aim of this study was to assess the effects of a home
exercise programme, based on aerobic training and muscle
strength training, in adult patients with CF, for a period of 3
months.
Methods
The study comprised a prospective, randomised controlled
clinical trial, with an intention to treat analysis, and
consecutively included patients attended through the Pro-
gramme for Adults with CF at the Porto Alegre Clinical
Hospital (HCPA) where volunteers stepped up. The protocol
was approved by the Ethics Committee at the HCPA (07164)
and a free informed term of consent was signed by each
patient.
The study included patients diagnosed with CF in
accordance with the criteria of the consensus [1], 16 years
of age or older, with at least 30 days of clinical respiratory
disease stability. Patients who refused to take part in the
study, pregnant ladies, individuals with heart disease, or-
thopaedic or traumatological problems, were excluded.
The assessment of the study included: a 6 min walk test
(6 MWT), muscle strength test, spirometry and quality of
life questionnaire. These assessments were carried out at
two moments: at the start and after three months of con-
ducting the trials. These assessments were carried out by
one of the researchers who was blind to the randomisation
and the intervention, throughout the study. This researcher
was responsible for controlling the filing of all the test re-
sults and transference of the test results to a database,numbered, with no nominal identification to keep the
process a blind study for all the other authors.
The 6 MWT was carried out in accordance with the
guidelines of the American Thoracic Society [19]. The total
distance walked in 6 min was recorded in meters and in the
% of the predicted distance [20]. The peripheral oxygen
saturation (SpO2) were measured by means of a pulse
oxymeter (NPB-40; Nellcor Puritan Bennett; Pleasanton,
CA, EUA). The perception of the sensation of dyspnoea and
fatigue of the lower limbs were recorded according to the
Borg scale [21].
Measuring muscle strength consisted of a one-repetition
maximum strength test (1 RM). The 1 RM test is defined as
the maximum weight lifted once during the performance of
a standardised weight lifting exercise. The 1 RM test in-
volves two muscle groups: elbow flexors and knee extensors
[22].
Spirometry was performed by means of a spirometer
(MasterScreen, v4.31, Jaeger, Wu¨rzburg, Germany). Forced
vital capacity (FVC), forced expiratory volume in 1 s (FEV1)
and a FEV1/FVC ratio were recorded. The test was carried
out in accordance with the reproducibility and accept-
ability criteria of the Brazilian Society of Pneumology and
Tisiology [23].
The quality of life was assessed by the questionnaire
specifically for CF [24] (CFQ e Cystic Fibrosis Question-
naire), and by a questionnaire of general scope Medical
Outcomes Study-36 Item Short-Form Health Survey (SF-36),
also valid for the Portuguese language [25].
After the first assessment, the patients were submitted
to the process of randomisation. This process uses a com-
puter programme (Random Allocation Software version 1.0,
developed by M. Saghaei, MD., Department of Anaesthesia,
University of Medical Sciences, Isfahan, Iran), in blocks of
six patients. The patients were allocated to two groups: an
exercise group (G1) and a control group (G2).
The patients randomised for G2 continued receiving
standard follow-up from the adult programme physiother-
apist, every two months. In this follow-up the patients were
advised on frequency and techniques of respiratory phys-
iotherapy and on the practice of physical exercise.
The patients randomised for G1, as well as follow-up
from the adult programme physiotherapist, they were
advised, to do a specific home exercise programme.
After randomisation, the first meeting was booked for
providing the training instructions, providing available
material for the exercise and the patient was acquainted
with its use. These orientations were reinforced at each
return visit to the outpatient department and through
weekly telephone contact during the three month period.
The exercise protocol was based on aerobic training and
muscle strength training to be performed daily. The pa-
tients received printed guidance material and practical
demonstration by the researcher, on the appropriate per-
formance of each physical exercise recommended by the
protocol.
For muscle strength training, the patients received
practical guidance and printed copies of the exercise pro-
tocol for strengthening muscles. The patients were advised
to perform the protocol daily.
The main outcome of the study was defined as the
variation on the score for quality of life. The secondary
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on the 6 MWT and the variation of maximum load reached
on the 1 RM test.
The estimation of the calculation for sample size was
done using the quality of life variable (SF-36). To reach a
difference of 5 points between two groups for the quality of
life questionnaire, with standard deviation of 5, with a
power of 90% and level of significance 0.05, 23 patients
would be needed in each group [24].
Statistical analysis
The data were expressed in number of cases (proportion),
average  SD or median (interquartile range). The com-
parisons between the categorical variables were done by
the chi-square test with adjusted standardised residuals,
applying Yates correction or the Fisher exact test when
indicated. The t test for independent samples was used for
the comparisons of the continuous variables with normal
distribution between two groups. The ManneWhitney U
Test was used for the comparison of ordinal variables or
continuous variables with no normal distribution.
Imputation of missing data was used for two patients
who did not participate in the second assessment of the
exercise programme, because they were submitted to a
lung transplant during the follow-up process. The Statisti-
cal Package for the Social Sciences, version 18.0(SPSS Inc.,
Chicago, IL, USA) was used for the imputation of data, and
from the original example 5 database were generated with
values estimated for these two patients in the second
moment of the study. The values of these 5 database were
added for the generation of a single database with anFigure 1 Flow diagraverage of values for these database. This single database
was used as reference for the whole statistical analysis of
this study [26].
The data was analysed using the SPSS programme
version18.0. The level of statistical significance was
established at p < 0.05. All the statistical tests used were
bicaudal.
Results
In the period between April, 2008 and March 2011, 60 pa-
tients were invited for inclusion in the study. Of these, 19
refused to participate for the following reasons: 6 argued
that they already did regular physical activity, 5 did not
have time for doing exercise, 3 did not like to exercise at
home, 3 did not want to do any physical activity, 1 did not
like to participate in clinical trials, 1 was trying to get
pregnant. Therefore, 41 patients were included in the
study. Fig. 1 presents flow diagram for the study.
Twenty-seven of the patients studied (65.9%) were fe-
male. The average age was 24.73  7.57 years old, the
average FEV1 was 57.95  25.15% of the predicted and all
the patients were Caucasian.
Table 1 shows the comparison of general characteristics
between the exercise and control groups. Nineteen pa-
tients were randomised for the exercise group and 22 for
the control group. The exercise group presented a BMI
significantly lower than the control group (p Z 0.011).
There was no significant difference between the two groups
for other characteristics.
Table 2 presents the comparison of dominions of quality
of life in cystic fibrosis and SF-36 between the interventionam for the study.
Table 1 Comparison of general characteristics between
intervention and control groups.
Variables Exercise
(n Z 19)
Control
(n Z 22)
p
Agea (years) 23.8  8.3 25.4  6.9 0.407
Sexb (male/female) 7/12 7/15 0.804
BMIa (Kg/m2) 19.8  2.4 21.4  2.1 0.011
FEV1
a (% predicted) 58.3  27.6 57.6  22.7 0.709
FVCa (% predicted) 71.6  2.9 71.5  19.0 0.984
Physical activityc
(% of yes)
31.6% 31.8% 0.825
Distance in 6 MWTa (metres) 540.2  79.5 549.0  36.8 0.643
SpO2 at rest
a (%) 95.8  2.3 96.8  2.0 0.165
Chi-square test for categorical variables; t test for independent
samples for continuous variables with normal distribution.
a Values expressed in average  SD.
b Values expressed in number of cases.
c Values expressed in %. BMI Z body mass index;
FEV1 Z forced expiratory volume in 1 s; FVC Z forced vital
capacity; 6 MWT Z 6 min walk test; SpO2 Z peripheral oxygen
saturation.
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significant differences observed in the assessment of the
different dominions of quality of life for the two ques-
tionnaires used [24,25].Table 2 Comparison of dominions of quality of life in
cystic fibrosis and SF-36 between exercise and control
groups at baseline.
Dominions Exercise
(n Z 19)
Control
(n Z 22)
p
QoLQ e physical 58 (45/87) 64 (44/81) 1.000
QoLQ e body image 77 (55/77) 77 (66/88) 0.211
QoLQ e digestion 88 (88/100) 88 (74/100) 0.187
QoLQ e respiratory 55 (50/72) 55 (38/61) 0.311
QoLQ e emotional 86 (66/93) 73 (46/86) 0.060
QoLQ e social 61 (44/72) 63 (48/77) 0.572
QoLQ e food 88 (77/100) 100 (77/100) 0.843
QoLQ e treatment 55 (44/66) 55 (38/66) 1.000
QoLQ e vitality 66 (58/75) 62 (41/75) 0.348
QoLQ e health 55 (33/77) 44 (33/77) 0.968
QoLQ e weight 33 (33/66) 66 (33/100) 0.237
QoLQ e social role 83 (58/91) 83 (64/91) 0.749
SF-36 e functional
capacity
75 (70/90) 80 (63/95) 0.645
SF-36 e physical aspects 75 (25/100) 87 (50/100) 0.280
SF-36 e pain 72 (51/84) 61 (51/88) 0.691
SF-36 e general health 52 (47/57) 52 (35/57) 0.863
SF-36 e vitality 65 (50/80) 57 (38/66) 0.192
SF-36 e social aspects 62 (50/87) 75 (59/100) 0.611
SF-36 e emotional aspects 66 (33/100) 66 (33/100) 0.956
SF-36 e mental health 76 (56/84) 70 (55/84) 0.732
Values expressed in median (percentile 25/percentile 75).
QoLQ Z quality of life questionnaire in cystic fibrosis for pa-
tients of age  14 years. SF-36 Z generic questionnaire on
quality of life Medical Outcomes Study 36-item Short-Form
Health Survey. ManneWhitney U Test.Table 3 shows the comparison of differences between
exercise and control groups after 3 months of follow-up.
The exercise group presented a significant increase in
muscle strength in upper limbs (UULL) compared with the
control group on the 1 RM test (pZ 0.011 for the left upper
limb and pZ 0.029 for the right upper limb). There was no
significant difference in the variables related to the 6 MWT.
Table 4 presents the comparison of differences in the
dominions of quality of life in cystic fibrosis and SF-36 be-
tween exercise and control groups after three months of
study. No statistically significant differences were observed
between different dominions of quality of life for the two
questionnaires used.
Discussion
This randomised and controlled clinical trial showed that,
in adult patients with CF, a home exercise programme,
based on aerobic training and muscle strength training,
coupled with supervision by telephone, had a positive
impact on the exercise group after the 3 months of con-
ducting the trial, contributing to the significant increase of
muscle strength in UULL of this group of patients, although,
no effect on the scores of the general quality of life have
been observed nor specifically for CF nor on the distance
walked on the 6 MWT.Table 3 Comparison of differences between intervention
and control groups after 3 months of follow-up.
Variables Exercise
(n Z 19)
Control
(n Z 22)
p
DFEV1 (% predicted) 6.0  16.1 2.0  7.3 0.306
DFVC (% predicted) 6.8  17.7 3.5  8.3 0.445
6 MWT
DDistance (meters) 7.0  39.8 6.2  37.5 0.947
DDistance (% predicted) 1.2  5.9 3.1  9.9 0.478
DSpO2 at rest (%) 0.1  1.3 1.0  2.1 0.097
DSpO2 at the end
of 6 MWT (%)
1.3  5.4 1.3  2.9 0.052
DRR at the end of
6 MWT (irpm)
0.3  5.0 0.7  9.5 0.652
DHR at the end of
6 MWT (bpm)
0.4  20.7 5.1  24.6 0.510
DBorg dyspnoea at rest 0.1  0.4 0.1  0.8 0.985
DBorg dyspnoea at
the end of 6 MWT
0.4  2.1 0.3  1.8 0.863
DBorg fatigue at rest 0.02  0.8 0.0  0.9 0.944
DBorg fatigue at the
end of 6 MWT
0.9  2.6 0.3  1.2 0.267
D1 RM in LUL 1.2  2.2 0.2  1.0 0.011
D1 RM in RUL 1.0  1.7 0.0  0.9 0.029
D1 RM in LLL 2.4  1.9 0.8  2.8 0.053
D1 RM in RLL 2.1  2.0 1.0  3.2 0.199
Values expressed in average  SD. D Z difference.
FEV1 Z forced expiratory volume in 1 s; FVC Z forced vital
capacity; 6 MWT Z 6 min walk test; SpO2 Z peripheral oxygen
saturation. RR Z respiratory rate; HR Z heart rate;
1 RM Z one-repetition maximum strength test; LUL Z left
upper limb; RUL Z right upper limb; LLL Z left lower limb;
RLL Z right lower limb. t test for independent samples.
Table 4 Comparison of differences dos dominions of quality of life in cystic fibrosis and SF-36 between intervention and
control groups.
Dominions Exercise (n Z 19) Control (n Z 22) p
DQoLQ e physical 6.1  17.50 (4/8) 2.4  17.50 (10/13) 0.742
DQoLQ e body image 3.3  17.20 (11/22) 3.0  22.20 (2/11) 0.915
DQoLQ e digestive 1.0  9.00 (4/0) 0.5  11.10 (0/0) 0.953
DQoLQ e respiratory 3.8  10.60 (0/11) 4.7  13.40 (1/7) 0.925
DQoLQ e emotional 1.2  13.00 (6/6) 4.3  17.80 (13/6) 0.458
DQoLQ e social 1.1  18.50 (11/5) 1.7  16.40 (5/11) 0.822
DQoLQ e food 0.3  16.80 (11/6) 2.0  15.10 (11/0) 0.913
DQoLQ e treatment 2.0  15.50 (11/0) 2.5  21.30 (11/11) 0.850
DQoLQ e vitality 1.2  21.00 (16/8) 2.6  16.50 (8/10) 0.579
DQoLQ e health 1.7  22.00 (11/16) 3.0  12.40 (11/0) 0.382
DQoLQ e weight 4.6  33.90 (0/33) 12.1  24.20 (0/11) 0.410
DQoLQ e social role 0.8  15.70 (8/8) 1.8  11.40 (2/0) 0.935
DSF-36 e functional capacity 2.0  18.10 (10/15) 2.0  22.40 (11/10) 0.916
DSF-36 e physical aspects 11.8  49.50 (25/50) 6.8  37.90 (6/31) 0.705
DSF-36 e pain 7.2  29.2e10 (28/11) 8.0  19.90.5 (0/17) 0.100
DSF-36 e general health 3.7  14.15 (5/10) 3.5  15.4e2.5 (11/5) 0.197
DSF-36 e vitality 1.2  21.65 (15/20) 7.5  16.15 (1/21) 0.416
DSF-36 e social aspects 15.2  38.70 (0/33) 21.2  43.00 (0/66) 0.989
DSF-36 e emotional aspects 4.7  25.80 (12/37) 4.5  27.60 (12/25) 0.914
DSF-36 e mental health 0.8  18.30 (12/12) 0.9  16.82 (9/13) 0.752
Values expressed in median (percentile 25/percentile 75).
DZ Difference. QoLQZ quality of life questionnaire in cystic fibrosis for patients of age  14 years. SF-36Z generic questionnaire on
quality of life Medical Outcomes Study 36-item Short-Form Health Survey.
ManneWhitney U Test.
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training in patients with CF showed several benefits
including an increase in muscle mass, muscle strength,
body weight and a decrease in residual volume, attributing
greatest flexibility and thoracic mobility. However, many of
these studies present methodological limitations. Most of
them are non-controlled studies, of small sample size, and
a short period of intervention and also non-randomised.
Orenstein et al. [15] studied 67 patients with CF and age
between 8 and 18. The patients were randomised for two
groups, the aerobic training group and the strength training
group for the UULL. It was a guided home programme; the
patients were reassessed after 6 months and at the end of a
year. It was concluded that both sets of training increased
muscle strength in UULL and improved the physical toler-
ance of patients with CF. According to some authors, the
importance of an increase in muscle strength in patients
with CF is directly related to an improvement in tolerance
to exercise in these patients [11,15].
The fact that this study does not show any gain in muscle
strength lower limbs (LLLL) may be explained by the dif-
ference size of the muscle groups exercised, that is, the
UULL muscle groups are shorter than in the LLLL which
enables the faster gain of trophism in these muscle fibres.
This fact may contribute to the increase in more efficient
muscle strength in UULL. Apart from this, the length of time
the study was conducted may have been too short to show
the same effect in training in both muscle groups [22].
However, it is noteworthy that, in this study, there was no
improvement in the aerobic condition of the patients
(p> 0.05). A possible explication for this fact could be that inmany of the patients the combination of previous illness and
lack of physical activity has contributed to the low tolerance
to exercise and limited the gain in fitness [5,14]. Some pa-
tients with initial low physical fitness and poor tolerance to
exercise are limited because they are badly trained and,
accordingly, show great potential for improvement, but
perhaps need a longer period of training than the three
months of the study. On the other hand, patients with amore
advanced illness, precarious pulmonary function and loss of
peripheral skeletal muscle mass have a lower potential for
improvement and gaining aerobic fitness.
The incremental shuttle walking test (ISWT) is widely
used in patients with chronic respiratory diseases and
proves to be more sensitive than the 6 MWT to detect early
functional capacity of patients change, since the SWT re-
quires more physical effort compared to the 6 MWT is a test
that depends on the patient’s wishes. Perhaps one of the
hypotheses for the group of patients randomized to the
intervention have not shown an increase in aerobic capac-
ity, can be explained by the 6 MWT not be so sensitive to
this population [29]. The ISWT can be considered a valid
and reliable test to assess maximal exercise capacity in
individuals with chronic respiratory diseases [29].
Furthermore, patients had moderate lung function
decline and this favoured for them to complete the 6 MWT
with ease [29]. A recent study [11], investigated the prev-
alence of muscle weakness and its relation to the tolerance
to exercise in adult patients with CF. Fifty-six percent of
the patients with CF presented muscle weakness in the
quadriceps muscle and 75% presented distance walked on
the 6 MWT lower than normal. Adult patients with CF
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tolerance to exercise and that the lack of physical activity
significantly contributes to these alterations.
The quality of life, assessed through the two question-
naires [24,25], presented no modifications while following
the study (p > 0.05). Hebestreit et al. [30] determined the
effects of a supervised controlled training programme in
patients with CF and of age between 12 and 40 years old.
The intervention promoted positive effects on the con-
sumption of VO2max, the FVC% predicted and the quality of
life of the patients with CF. The improvement in the quality
of life of patients who took regular physical exercise
seemed to be related to the long term training pro-
grammes, with good adherence and adaptation to the
specific needs and preferences of each individual.
Two patients were submitted to a lung transplant during
the follow-up period of the study. In these cases imputa-
tions of missing data were used as a method of dealing with
the lack of assessment which should have been carried out
in the second phase of the study [26]. The study rigorously
followed the methods established by the clinical trials for
intention to treat.
The present study shows some limitations. The fact of not
having used the measurement of VO2max consumption ob-
tained from the cardiopulmonary force test as a measure for
the outcome may have influenced the sensitivity for identi-
fying variations in the aerobic condition of the patients
studied. Another possible limitation was the length of time
the study was conducted for, stipulated as three months,
which may have been insufficient to show any significant
impact onphysical condition and in thequality of life of these
individuals. Apart from this, the refusal of many of the pa-
tients to participate in the study, may have created a bias on
excluding patients unaccustomed to exercise and passive to
the potential benefit or this therapeutic approach.
The contribution of the study is in the way the practise
of physical exercise is administered in the patient’s home,
supervised at a distance, as a way of facilitating and
broadening access to this therapeutic recommendation,
even though the benefit has been of a small magnitude.
In conclusion, the study demonstrated that a home ex-
ercise programme in adult patients with CF, during the
three months, including aerobic and muscle strength
training, no improvement in the quality of life of the pa-
tients who received the intervention. The secondary
outcome of the study was to gain muscular strength in the
upper limbs in patients randomized to the intervention.
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